S4994Referred to Committee

A bill to amend the Internal Revenue Code of 1986 to provide for credits against tax for domestic manufacturing of critical medical supplies and drugs.

Share:
Introduced
In Committee
3
Passed One Chamber
4
Passed Both
5
Signed into Law
119th
Congress
2026-07-15
Introduced
0
Cosponsors
S
ⓘ
Type

Sponsor

Marsha Blackburn
Marsha Blackburn
Republican · TN · Senator
Votes with party: 74.8% (813 recorded votes)

Full profile: /officials/B001243

Source: Congress.gov · FEC

Cosponsors (0)

Members who have signed on to support this bill since introduction. Source: Congress.gov.

No cosponsors on record. Bills can pass without cosponsors — this often means the sponsor introduced the bill alone, either because it's a messaging bill, a chairman's mark, or simply early in the legislative cycle.

Latest Action

The most recent step in the bill's legislative path. Committee Activity below shows referrals and reports; the full action-by-action history including floor proceedings lives at Congress.gov →

Read twice and referred to the Committee on Finance.

2026-07-15

Source: Congress.gov

Committee Activity

Currently in

Plain-English Summary

The proposal would give tax breaks to American companies that manufacture critical medical supplies and drugs domestically instead of importing them from other countries. These tax credits would reduce the amount of federal income taxes that qualifying manufacturers owe, potentially making it cheaper for them to produce medicines and medical equipment in the United States. The goal is to encourage domestic production of essential medical products and reduce reliance on foreign manufacturing.

AI-assisted summary generated from the official bill metadata (title, subjects, actions) sourced from Congress.gov. Cached and reviewed. Always verify against the official text linked below.

Full bill text is not yet cached locally.
Open text viewRead on Congress.gov

Related legislation

Bills by the same sponsor or covering overlapping subjects.